Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples